C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/505 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01) A61P 25/30 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2663511
The present invention relates to compounds of Formula (I), pharmaceutical compositions thereof, and use thereof as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric and neuroendocrine disorders, neurological diseases, and metabolic syndrome.
La présente invention concerne des composés représentés par la formule (I), des compositions pharmaceutiques à base de ces composés, et leur utilisation comme antagonistes du récepteur du CRF1 (facteur 1 de libération de la corticotropine) pour le traitement de troubles psychiatriques et neuroendocriniens, de maladies neurologiques et du syndrome métabolique.
Chen Zhaogen
Hamdouchi Chafiq Hamdouchi
Hembre Erik James
Hipskind Philip Arthur
Myers Jason Kenneth
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Thiazole pyrazolopyrimidines as crf1 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazole pyrazolopyrimidines as crf1 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole pyrazolopyrimidines as crf1 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2004931